For the traditional Chinese medicine field, HeLiKangYuan launched the MD6100 series of Chinese medicine granule dispensing equipment, which provides a complete solution for the promotion of Chinese medicine granule formula, covering the storage of Chinese medicine granule formula, prescription management, automatic dispensing, drug encapsulation, equipment management, etc. It has been successfully applied in more than a hundred of traditional Chinese medicine medical institutions, and it is still growing rapidly, which realizes the innovative dispensing of Chinese medicine in the Chinese medicine industry. It has been successfully applied to more than a hundred TCM medical institutions and is still growing rapidly, realizing an innovative change in the dispensing of medicines in the TCM industry.
For the field of genetic and life science instrumentation, Helicon has launched the Biochip Hybridizer for biomolecular reaction and the Biochip Analyzer for biomolecular signal detection and analysis, which provides a molecular biology analysis platform for rapid medical diagnosis. By providing high-quality products, services and integrated system solutions in the field of medical automation, Heili Kangyuan provides advanced automation equipments and technologies for the pharmaceutical industry, promotes industrial upgrading, and is a health company that makes outstanding contributions to people's livelihood.
Legal representative: Shao Boqing
Establishment date: 2010-06-04
Registered capital: 115 million RMB
Region: Beijing
Unified social credit code: 911103025568437670
Operation status: open
Industry：Scientific Research and Technology Service Industry
Company Type：Limited Liability Company (Sino-foreign Equity Joint Venture)
English Name：Beijing Hollycon Medical Technology Co.,Ltd.
Personnel Scale：100-500 Personnel
Enterprise Address：Beijing Beijing Economic and Technological Development Zone, Disheng Middle Road, No. 2, Building 7, 1, 2, 3 floors
Business Scope: pharmaceutical special equipment, packaging special equipment, technology development, technology transfer, technical advice, technical services; sales of self-produced products; computer software, machinery and equipment (excluding motor vehicles), electronic components, electrical apparatus and instruments wholesale, commission agent; import and export, import and export of goods and agents, Technology import and export (design quota license management, special provisions of the management of goods in accordance with relevant state regulations); the production of Class I medical devices: medical instruments and equipment, nucleic acid extractor only; the production of pharmaceutical equipment, packaging equipment; the production of Class II medical devices: PCR instrumentation products only; the production of Class III medical devices: PCR instrumentation products only. (Production of Class III medical devices: PCR instrument products only; production of Class II medical devices: PCR instrument products only; and projects subject to approval in accordance with the law, after approval by the relevant departments to carry out business activities in accordance with the approved content. The company was a domestic-funded enterprise before July 18, 2016, and changed to a foreign-invested enterprise on July 18, 2016.)